Anti-HER2 antibodies and methods of use
US10377825B2 · kind B2 · utility
0Cited by
2References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2017 |
| Grant date | Aug 13, 2019 |
| Priority date | — |
| Expiry date | Feb 7, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides anti-HER2 antibodies, including anti-HER2 antibodies of improved stability or affinity, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.